Reduced late asthmatic response by repeated low-dose allergen exposure Source: Eur Respir J 2001; 17: 872-880 Year: 2001
Optimum dosing regimen for repeated low dose allergen challenge in chronic allergic asthma Source: Eur Respir J 2001; 18: Suppl. 33, 103s Year: 2001
Bronchial challenge with flour: early response is dependent on the dose of activated allergen inhaled Source: Eur Respir J 2002; 20: 409-416 Year: 2002
A monoclonal antibody to IL-1B attenuates the late asthmatic response to antigen challenge in patients with mild asthma Source: Annual Congress 2006 - Novel treatments for asthma Year: 2006
Tolerance to the protective effect of salmeterol on allergen challenge in mild untreated asthmatics and in moderate asthmatics on inhaled corticosteroid treatment Source: Eur Respir J 2001; 18: Suppl. 33, 103s Year: 2001
Sputum eosinophil counts in a large population of mild-to-moderate asthmatics: distribution, relationship with methacholine bronchial responsiveness and influence of a regular treatment with low doses of inhaled corticosteroids Source: Eur Respir J 2001; 18: Suppl. 33, 531s Year: 2001
The immune characteristics of inhalational tolerance induced by prolonged allergen exposure Source: Annual Congress 2007 - Regulation of allergic airway inflammation in animal models of asthma Year: 2007
Eosinophil apoptosis in bronchial tissue after low dose allergen exposure in mild asthma Source: Eur Respir J 2005; 26: Suppl. 49, 577s Year: 2005
The effect of single dose montelukast and desloratadine, alone and in combination, on the allergen induced late airway response in atopic asthma Source: Annual Congress 2008 - New mechanisms in the pathogenesis of asthma and its response to treatment Year: 2008
Ciclesonide 80 μg once daily reduces early and late asthmatic reaction, sputum eosinophils and serum ECP in asthma patients challenged with allergens Source: Eur Respir J 2005; 26: Suppl. 49, 254s Year: 2005
Non invasive markers of inflammatory response to ozone exposure in stable asthmatic subjects under regular treatment Source: Eur Respir J 2005; 26: Suppl. 49, 386s Year: 2005
The effect of smoking on the response to nasal antigen challenge in patients with allergic rhinitis Source: Eur Respir J 2002; 20: Suppl. 38, 217s Year: 2002
Histamine challenges discriminate between symptomatic and asymptomatic children Source: Eur Respir J 2001; 17: 246-253 Year: 2001
Bronchial effects of formaldehyde on inhaled allergenic challenge in patients with intermittent asthma Source: Annual Congress 2005 - Cleaning and cooking: a risk for occupational and household asthma Year: 2005
Low exposure to inhaled formaldehyde: effect on allergen bronchial response in asthmatics sensitized to mite Source: Eur Respir J 2006; 28: Suppl. 50, 592s Year: 2006
The role of T-lymphocytes in food allergy and asthma Source: Annual Congress 2005 - Food allergy, atopic dermatitis and asthma Year: 2005
Specific inhalation challenge causes minor changes in nasal proteome of work-related asthma patients Source: International Congress 2018 – Occupational and environmental lung diseases: asthma and the airways Year: 2018
Bronchial cell infiltrate after two weeks, repeated low-dose allergen exposure in atopic asthma: protection by inhaled steroids? Source: Eur Respir J 2002; 20: Suppl. 38, 588s Year: 2002
A single nasal allergen challenge increases induced sputum inflammatory parameters in non-asthmatic patients with seasonal allergic rhinitis Source: Eur Respir J 2001; 18: Suppl. 33, 163s Year: 2001
Late Breaking Abstract - Multiple ascending dose study of the inhaled IL-4Ra antagonist, AZD1402/PRS-060, in mild asthmatics demonstrates robust FeNO reduction and a promising clinical profile for the treatment of asthma Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies Year: 2019